Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience.
暂无分享,去创建一个
A. Coppola | F. Riccardi | A. Tagliaferri | G. Rivolta | A. Benegiamo | Gabriele Quintavalle | R. Rossi | Annalisa Matichecchia